LUC00072I2 - Niraparib ou un sel pharmaceutiquement acceptable, stéréoisomère ou tautomère de celui-ci, notamment le tosylate ou un hydrate, particulièrement le tosylate monohydraté - Google Patents

Niraparib ou un sel pharmaceutiquement acceptable, stéréoisomère ou tautomère de celui-ci, notamment le tosylate ou un hydrate, particulièrement le tosylate monohydraté Download PDF

Info

Publication number
LUC00072I2
LUC00072I2 LU00072C LUC00072C LUC00072I2 LU C00072 I2 LUC00072 I2 LU C00072I2 LU 00072 C LU00072 C LU 00072C LU C00072 C LUC00072 C LU C00072C LU C00072 I2 LUC00072 I2 LU C00072I2
Authority
LU
Luxembourg
Prior art keywords
tosylate
pharmaceutically acceptable
niraparib
tautomer
stereoisomer
Prior art date
Application number
LU00072C
Other languages
English (en)
Original Assignee
Msd Italia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37809722&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LUC00072(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Msd Italia Srl filed Critical Msd Italia Srl
Publication of LUC00072I2 publication Critical patent/LUC00072I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LU00072C 2007-01-10 2018-05-03 Niraparib ou un sel pharmaceutiquement acceptable, stéréoisomère ou tautomère de celui-ci, notamment le tosylate ou un hydrate, particulièrement le tosylate monohydraté LUC00072I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0700432.8A GB0700432D0 (en) 2007-01-10 2007-01-10 Therapeutic compounds

Publications (1)

Publication Number Publication Date
LUC00072I2 true LUC00072I2 (fr) 2018-07-04

Family

ID=37809722

Family Applications (1)

Application Number Title Priority Date Filing Date
LU00072C LUC00072I2 (fr) 2007-01-10 2018-05-03 Niraparib ou un sel pharmaceutiquement acceptable, stéréoisomère ou tautomère de celui-ci, notamment le tosylate ou un hydrate, particulièrement le tosylate monohydraté

Country Status (21)

Country Link
CN (1) CN101578279B (fr)
AT (1) ATE502933T1 (fr)
CR (1) CR10910A (fr)
DE (1) DE602008005711D1 (fr)
DK (2) DK2109608T3 (fr)
ES (3) ES2509115T3 (fr)
GB (1) GB0700432D0 (fr)
HN (1) HN2009001260A (fr)
HU (1) HUE044513T2 (fr)
LT (1) LT2805945T (fr)
LU (1) LUC00072I2 (fr)
ME (1) ME03481B (fr)
MY (1) MY147789A (fr)
NI (1) NI200900135A (fr)
NZ (1) NZ578256A (fr)
PE (1) PE20081558A1 (fr)
PT (3) PT2805945T (fr)
SI (2) SI2336120T1 (fr)
TW (1) TWI528961B (fr)
UA (1) UA97658C2 (fr)
ZA (1) ZA200903898B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106496187A (zh) * 2016-09-14 2017-03-15 陕西科技大学 一种制备PARP抑制剂Niraparib的合成方法
CN106432188A (zh) * 2016-09-17 2017-02-22 青岛辰达生物科技有限公司 一种抗癌药2‑[4‑((3s)‑3‑哌啶基)苯基]‑2h‑吲唑‑7‑甲酰胺的制备方法
CN106432187A (zh) * 2016-09-17 2017-02-22 青岛云天生物技术有限公司 2‑[4‑(‑3‑哌啶基)苯基]‑2h‑吲唑‑7‑甲酰胺的手性拆分方法
CN106632244A (zh) * 2016-09-30 2017-05-10 陕西科技大学 一种制备抗癌药物Niraparib的新型合成方法
CN106467513A (zh) * 2016-09-30 2017-03-01 陕西科技大学 一种制备Niraparib的合成方法
CN108201537A (zh) * 2016-12-16 2018-06-26 苏州苏融生物医药有限公司 一种尼拉帕尼缓控释药物组合物及其用途
CA3058372A1 (fr) * 2017-03-27 2018-10-04 Tesaro, Inc. Formulations de niraparib
CN109081828B (zh) * 2017-06-14 2021-03-26 上海时莱生物技术有限公司 聚(adp-核糖)聚合酶抑制剂、制备方法及用途
CA3076907A1 (fr) 2017-09-26 2019-04-04 Tesaro, Inc. Formulations de niraparib
CN108084157A (zh) * 2018-02-12 2018-05-29 安庆奇创药业有限公司 一种尼拉帕尼的合成方法
CN108203404A (zh) * 2018-03-02 2018-06-26 上海博邦医药科技有限公司 (r)-3-苯基哌啶或/和(s)-3-苯基哌啶以及尼拉帕尼的手性中间体的合成方法
JP2023514794A (ja) 2020-02-24 2023-04-10 フーカン（シャンハイ） ヘルス テクノロジー カンパニー、 リミテッド ポリａｄｐリボースポリメラーゼ阻害剤の抗コロナウイルス応用

Also Published As

Publication number Publication date
ATE502933T1 (de) 2011-04-15
ES2728199T3 (es) 2019-10-22
GB0700432D0 (en) 2007-02-21
CN101578279B (zh) 2013-07-17
PT2336120E (pt) 2014-10-01
ME03481B (fr) 2020-01-20
UA97658C2 (ru) 2012-03-12
NZ578256A (en) 2011-12-22
PT2805945T (pt) 2019-06-06
SI2336120T1 (sl) 2014-10-30
DK2109608T3 (da) 2011-07-11
CR10910A (es) 2010-01-19
LT2805945T (lt) 2019-06-25
NI200900135A (es) 2010-08-30
HN2009001260A (es) 2012-03-26
PE20081558A1 (es) 2008-10-30
MY147789A (en) 2013-01-31
DK2336120T3 (da) 2014-10-06
SI2109608T1 (sl) 2011-07-29
ZA200903898B (en) 2010-04-28
TW200836731A (en) 2008-09-16
HUE044513T2 (hu) 2019-10-28
PT2109608E (pt) 2011-05-30
CN101578279A (zh) 2009-11-11
ES2509115T3 (es) 2014-10-17
TWI528961B (zh) 2016-04-11
ES2362214T3 (es) 2011-06-29
DE602008005711D1 (de) 2011-05-05

Similar Documents

Publication Publication Date Title
LUC00072I2 (fr) Niraparib ou un sel pharmaceutiquement acceptable, stéréoisomère ou tautomère de celui-ci, notamment le tosylate ou un hydrate, particulièrement le tosylate monohydraté
MX2009007200A (es) Indazoles sustituidos con amida como inhibidores de poli(adp-ribosa)polimerasa (parp).
MX2010005070A (es) Derivados de piridazinona como inhibidores de parp.
WO2007138351A3 (fr) Dérivés de pyridinone et de pyridazinone inhibiteurs de la poly(adp-ribose)polymérase (parp)
MA37866B1 (fr) Dérivés de type aza-indazole ou diaza-indazole pour le traitement de la douleur
MX2012002179A (es) Compuestos heterociclicos de oxima.
MX346186B (es) Inhibidores de proteina cinasas.
WO2010054278A3 (fr) Composés pour traiter les troubles inflammatoires
EA201270373A1 (ru) Ингибиторы jak2 и их применение для лечения миелопролиферативных заболеваний и злокачественной опухоли
EA201100580A1 (ru) Имидазопиридазинкарбонитрилы, используемые в качестве ингибиторов киназы
WO2008017883A3 (fr) Dérivés de 4-oxo-4,5-dihydropyrrolo[1,2-a]quinoxaline en tant qu'inhibiteurs de poly(adp-ribose)polymérase(parp)
MX2012001838A (es) Compuestos de hidrazona heterociclico y sus usos para tratar cancer e inflamacion.
TW201000488A (en) Heterocyclic derivatives
WO2012117000A8 (fr) 3-aminopyridines en tant qu'agonistes de gpbar1
MA32727B1 (fr) Pyrazolylaminopyridines au titre d'inhibiteurs de fak
WO2011147951A8 (fr) Dérivés de cycloamino comme antagonistes du gpr119
MY148254A (en) Tartrate derivatives for use as coagulation factor ixa inhibitors
MX2009009409A (es) Compuestos que tienen estructura aril-sulfonamidica utiles como inhibidores de metaloproteasas.
TH114424B (th) ยาสำเร็จรูปชนิดของแข็ง